• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

疏水性和氢键相互作用对 G 蛋白偶联胰高血糖素受体抑制剂 β-丙氨酸类似物活性的影响。

Effect of hydrophobic and hydrogen bonding interactions on the potency of ß-alanine analogs of G-protein coupled glucagon receptor inhibitors.

机构信息

Biophysical and Computational Chemistry Laboratory, Department of Chemistry, National Institute of Technology Karnataka, Surathkal, Mangalore, India.

出版信息

Proteins. 2020 Feb;88(2):327-344. doi: 10.1002/prot.25807. Epub 2019 Sep 10.

DOI:10.1002/prot.25807
PMID:31443129
Abstract

G-protein coupled glucagon receptors (GCGRs) play an important role in glucose homeostasis and pathophysiology of Type-II Diabetes Mellitus (T2DM). The allosteric pocket located at the trans-membrane domain of GCGR consists of hydrophobic (TM5) and hydrophilic (TM7) units. Hydrophobic interactions with the amino acid residues present at TM5, found to facilitate the favorable orientation of antagonist at GCGR allosteric pocket. A statistically robust and highly predictive 3D-QSAR model was developed using 58 β-alanine based GCGR antagonists with significant variation in structure and potency profile. The correlation coefficient (R ) and cross-validation coefficient (Q ) of the developed model were found to be 0.9981 and 0.8253, respectively at the PLS factor of 8. The analysis of the favorable and unfavorable contribution of different structural features on the glucagon receptor antagonists was done by 3D-QSAR contour plots. Hydrophobic and hydrogen bonding interactions are found to be main dominating non-bonding interactions in docking studies. Presence of highest occupied molecular orbital (HOMO) in the polar part and lowest unoccupied molecular orbital (LUMO) in the hydrophobic part of antagonists leads to favorable protein-ligand interactions. Molecular mechanics/generalized born surface area (MM/GBSA) calculations showed that van der Waals and nonpolar solvation energy terms are crucial components for thermodynamically stable binding of the inhibitors. The binding free energy of highly potent compound was found to be -63.475 kcal/mol; whereas the least active compound exhibited binding energy of -41.097 kcal/mol. Further, five 100 ns molecular dynamics simulation (MD) simulations were done to confirm the stability of the inhibitor-receptor complex. Outcomes of the present study can serve as the basis for designing improved GCGR antagonists.

摘要

G 蛋白偶联胰高血糖素受体 (GCGR) 在葡萄糖稳态和 2 型糖尿病 (T2DM) 的病理生理学中发挥着重要作用。位于 GCGR 跨膜域的变构口袋由疏水 (TM5) 和亲水 (TM7) 单元组成。与 TM5 上存在的氨基酸残基的疏水相互作用,被发现有利于 GCGR 变构口袋中拮抗剂的有利取向。使用具有显著结构和效力分布差异的 58 种基于 β-丙氨酸的 GCGR 拮抗剂,开发了一个统计稳健且高度可预测的 3D-QSAR 模型。所开发模型的相关系数 (R) 和交叉验证系数 (Q) 在 PLS 因子为 8 时分别为 0.9981 和 0.8253。通过 3D-QSAR 轮廓图分析了不同结构特征对胰高血糖素受体拮抗剂的有利和不利贡献。在对接研究中,发现疏水和氢键相互作用是主要的非键相互作用。拮抗剂中最高占据分子轨道 (HOMO) 存在于极性部分,最低未占据分子轨道 (LUMO) 存在于疏水区,这导致了有利的蛋白-配体相互作用。分子力学/广义 Born 表面积 (MM/GBSA) 计算表明,范德华力和非极性溶剂化能项是抑制剂热力学稳定结合的关键组成部分。高活性化合物的结合自由能被发现为-63.475 kcal/mol,而最低活性化合物表现出的结合能为-41.097 kcal/mol。此外,进行了五次 100 ns 分子动力学模拟 (MD) 以确认抑制剂-受体复合物的稳定性。本研究的结果可以为设计改进的 GCGR 拮抗剂提供依据。

相似文献

1
Effect of hydrophobic and hydrogen bonding interactions on the potency of ß-alanine analogs of G-protein coupled glucagon receptor inhibitors.疏水性和氢键相互作用对 G 蛋白偶联胰高血糖素受体抑制剂 β-丙氨酸类似物活性的影响。
Proteins. 2020 Feb;88(2):327-344. doi: 10.1002/prot.25807. Epub 2019 Sep 10.
2
Pharmacophore generation, atom-based 3D-QSAR, molecular docking and molecular dynamics simulation studies on benzamide analogues as FtsZ inhibitors.基于药效团生成、基于原子的 3D-QSAR、分子对接和分子动力学模拟研究苯甲酰胺类似物作为 FtsZ 抑制剂。
J Biomol Struct Dyn. 2018 Sep;36(12):3218-3230. doi: 10.1080/07391102.2017.1384401. Epub 2017 Oct 11.
3
3D QSAR, Docking, Molecular Dynamics Simulations and MM-GBSA studies of Extended Side Chain of the Antitubercular Drug (6S) 2-Nitro-6- {[4-(trifluoromethoxy) benzyl] oxy}-6,7-dihydro-5H-imidazo[2,1-b] [1,3] oxazine.抗结核药物(6S)2-硝基-6-{[4-(三氟甲氧基)苄基]氧基}-6,7-二氢-5H-咪唑并[2,1-b][1,3]恶嗪延长侧链的3D QSAR、对接、分子动力学模拟及MM-GBSA研究
Infect Disord Drug Targets. 2019;19(2):145-166. doi: 10.2174/1871526518666181015145545.
4
A mechanistic approach to explore novel HDAC1 inhibitor using pharmacophore modeling, 3D- QSAR analysis, molecular docking, density functional and molecular dynamics simulation study.一种利用药效团建模、3D-QSAR分析、分子对接、密度泛函和分子动力学模拟研究来探索新型HDAC1抑制剂的机制方法。
J Mol Graph Model. 2016 Nov;70:54-69. doi: 10.1016/j.jmgm.2016.09.008. Epub 2016 Sep 14.
5
Deciphering the crucial molecular properties of a series of Benzothiazole Hydrazone inhibitors that targets anti-apoptotic Bcl-xL protein.解析一系列苯并噻唑腙抑制剂针对抗凋亡 Bcl-xL 蛋白的关键分子特性。
J Biomol Struct Dyn. 2018 Aug;36(10):2654-2667. doi: 10.1080/07391102.2017.1365771. Epub 2017 Aug 24.
6
A combination of pharmacophore modeling, atom-based 3D-QSAR, molecular docking and molecular dynamics simulation studies on PDE4 enzyme inhibitors.关于磷酸二酯酶4(PDE4)酶抑制剂的药效团建模、基于原子的三维定量构效关系(3D-QSAR)、分子对接和分子动力学模拟研究的组合。
J Biomol Struct Dyn. 2016 Nov;34(11):2481-92. doi: 10.1080/07391102.2015.1119732. Epub 2016 Apr 12.
7
Insight into the structural requirements of thiophene-3-carbonitriles-based MurF inhibitors by 3D-QSAR, molecular docking and molecular dynamics study.通过三维定量构效关系、分子对接和分子动力学研究深入了解基于噻吩-3-腈的MurF抑制剂的结构要求。
J Recept Signal Transduct Res. 2017 Oct;37(5):522-534. doi: 10.1080/10799893.2017.1360354. Epub 2017 Aug 3.
8
Stepwise development of structure-activity relationship of diverse PARP-1 inhibitors through comparative and validated in silico modeling techniques and molecular dynamics simulation.通过比较和经过验证的计算建模技术和分子动力学模拟,逐步开发出不同 PARP-1 抑制剂的结构-活性关系。
J Biomol Struct Dyn. 2015;33(8):1756-79. doi: 10.1080/07391102.2014.969772. Epub 2014 Oct 28.
9
Insight into the interaction mechanism of human SGLT2 with its inhibitors: 3D-QSAR studies, homology modeling, and molecular docking and molecular dynamics simulations.深入了解人类SGLT2与其抑制剂的相互作用机制:3D-QSAR研究、同源建模、分子对接和分子动力学模拟。
J Mol Model. 2018 Mar 6;24(4):86. doi: 10.1007/s00894-018-3582-2.
10
Identification of anti-filarial leads against aspartate semialdehyde dehydrogenase of Wolbachia endosymbiont of Brugia malayi: combined molecular docking and molecular dynamics approaches.鉴定抗丝氨酸半醛脱氢酶的抗丝虫先导化合物:结合分子对接和分子动力学方法。
J Biomol Struct Dyn. 2019 Feb;37(2):394-410. doi: 10.1080/07391102.2018.1427633. Epub 2018 Feb 6.

引用本文的文献

1
Rational Design and Synthesis of a Novel Series of Thiosemicarbazone-Containing Quinazoline Derivatives as Potential VEGFR2 Inhibitors.新型含硫代氨基脲喹唑啉衍生物系列作为潜在VEGFR2抑制剂的合理设计与合成
Pharmaceutics. 2025 Feb 15;17(2):260. doi: 10.3390/pharmaceutics17020260.
2
Investigating the effect of , on using integrated computational approaches.使用综合计算方法研究……对……的影响。 (注:原文中两个“……”处内容缺失,以上是根据现有内容翻译的大致意思。)
In Silico Pharmacol. 2024 Nov 9;12(2):102. doi: 10.1007/s40203-024-00278-1. eCollection 2024.
3
Development of artificial photosystems based on designed proteins for mechanistic insights into photosynthesis.
基于设计蛋白质的人工光合系统的开发,以深入了解光合作用的机理。
Protein Sci. 2024 Oct;33(10):e5164. doi: 10.1002/pro.5164.
4
Discovery of A Novel Series of Quinazoline-Thiazole Hybrids as Potential Antiproliferative and Anti-Angiogenic Agents.发现新型喹唑啉-噻唑杂合体作为有潜力的抗增殖和抗血管生成剂。
Biomolecules. 2024 Feb 12;14(2):218. doi: 10.3390/biom14020218.
5
Structure Prediction and Potential Inhibitors Docking of Enterovirus 2C Proteins.肠道病毒2C蛋白的结构预测与潜在抑制剂对接
Front Microbiol. 2022 Apr 29;13:856574. doi: 10.3389/fmicb.2022.856574. eCollection 2022.
6
Molecular dynamics simulations, docking and MMGBSA studies of newly designed peptide-conjugated glucosyloxy stilbene derivatives with tumor cell receptors.新型肽缀合葡萄糖氧基二苯乙烯衍生物与肿瘤细胞受体的分子动力学模拟、对接和 MMGBSA 研究。
Mol Divers. 2022 Oct;26(5):2717-2743. doi: 10.1007/s11030-021-10354-9. Epub 2022 Jan 17.
7
Ligand-Receptor Interactions and Machine Learning in GCGR and GLP-1R Drug Discovery.配体-受体相互作用和机器学习在 GCGR 和 GLP-1R 药物发现中的应用。
Int J Mol Sci. 2021 Apr 14;22(8):4060. doi: 10.3390/ijms22084060.
8
Molecular mechanism of inhibition of COVID-19 main protease by β-adrenoceptor agonists and adenosine deaminase inhibitors using methods.使用 方法抑制 COVID-19 主蛋白酶的β-肾上腺素能受体激动剂和腺苷脱氨酶抑制剂的分子机制。
J Biomol Struct Dyn. 2022 Jul;40(11):5112-5127. doi: 10.1080/07391102.2020.1868337. Epub 2021 Jan 5.